Thienopyridine compounds which are potassium channel inhibitors are described. Pharmaceutical compositions comprising the compounds and their use in the treatment or prevention of cancer, arrhythmias, autoimmune diseases and inflammatory diseases, including gastric cancer, atrial fibrillation, type-2 diabetes mellitus, rheumatoid arthritis, type-1 diabetes, inflammatory bowel disorder and demyelinating disorders such as multiple sclerosis are also disclosed.
描述了一种
钾通道
抑制剂的噻
吡啶类化合物。还披露了包括这些化合物的药物组合物以及它们在治疗或预防癌症、心律失常、自身免疫疾病和炎症性疾病中的用途,包括胃癌、心房颤动、2型糖尿病、类风湿性关节炎、1型糖尿病、炎症性肠道疾病和多发性硬化等脱髓鞘疾病。